CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

NCT03671460 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: CD19 CAR-T cells

Sponsor

Tianjin Mycure Medical Technology Co., Ltd